We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.29%
This Fund
S&P 500
This Quarter Est. Return
+5.34%
1 Year Est. Return
+106.29%
3 Year Est. Return
+266.67%
5 Year Est. Return
+310.43%
10 Year Est. Return
+1,579.99%
AUM
$4.32B
AUM Growth
+$316M
Cap. Flow
-$173M
Cap. Flow %
-4%
Top 10 Hldgs %
10.31%
Holding
2,841
New
651
Increased
541
Reduced
445
Closed
892

Sector Composition

Rank Sector Weight
1 Financials 12.96%
2 Healthcare 8.24%
3 Technology 8.23%
4 Industrials 6.13%
5 Consumer Discretionary 5.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EOSE icon
1776
Eos Energy Enterprises
EOSE
$1.43B
$90.1K ﹤0.01%
60,887
EEX
1777
DELISTED
Emerald Holding
EEX
$88.9K ﹤0.01%
+25,116
New +$90.1K
VOXX
1778
DELISTED
VOXX International Corporation Class A
VOXX
$88.7K ﹤0.01%
+10,587
New +$96K
OSG
1779
DELISTED
Overseas Shipholding Group Inc.
OSG
$88.6K ﹤0.01%
+30,654
New +$89K
BIVI icon
1780
BioVie
BIVI
$10.2M
$88.4K ﹤0.01%
+114
New +$61.6K
BCAB icon
1781
BioAtla
BCAB
$5.53M
$88.2K ﹤0.01%
+214
New +$88.8K
AMPY icon
1782
CALL
Amplify Energy
AMPY
$168M
$87.9K ﹤0.01%
10,000
PL icon
1783
Planet Labs
PL
$8.1B
$87K ﹤0.01%
20,000
-137,280
-87% -$711K
LCTX icon
1784
Lineage Cell Therapeutics
LCTX
$282M
$86.7K ﹤0.01%
+74,094
New +$93.4K
CMPX icon
1785
Compass Therapeutics
CMPX
$358M
$86.2K ﹤0.01%
+17,130
New +$68.3K
NNOX icon
1786
Nano X Imaging
NNOX
$71M
$86.1K ﹤0.01%
+11,667
New +$129K
PBYI icon
1787
Puma Biotechnology
PBYI
$413M
$85.5K ﹤0.01%
+20,218
New +$69.8K
IMMR icon
1788
Immersion
IMMR
$246M
$85.2K ﹤0.01%
+12,119
New +$78K
EVLO
1789
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$84.8K ﹤0.01%
+2,635
New +$104K
RGF
1790
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
$83.9K ﹤0.01%
+1,055
New +$86K
DRH icon
1791
Diamondrock Hospitality Co
DRH
$2.59B
$83.9K ﹤0.01%
10,239
-2,764
-21% -$24K
BYRN icon
1792
Byrna Technologies
BYRN
$98.9M
$83.7K ﹤0.01%
+10,679
New +$79.9K
GTHX
1793
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$82.3K ﹤0.01%
+15,161
New +$127K
RWODR
1794
DELISTED
Redwoods Acquisition Corp. Rights
RWODR
$82.3K ﹤0.01%
700,000
POL.WS
1795
DELISTED
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
$80.9K ﹤0.01%
140,000
-12,426
-8% -$1.19K
LRMR icon
1796
Larimar Therapeutics
LRMR
$436M
$80.2K ﹤0.01%
+19,421
New +$66.3K
PNACR
1797
DELISTED
Prime Number Acquisition I Corp. Right
PNACR
$80.2K ﹤0.01%
445,500
ANNX icon
1798
Annexon
ANNX
$918M
$79.8K ﹤0.01%
+15,443
New +$84.9K
PHLT
1799
DELISTED
Performant Healthcare Inc
PHLT
$78.9K ﹤0.01%
+21,846
New +$51.1K
PPHPR
1800
DELISTED
PHP Ventures Acquisition Corp. Rights
PPHPR
$78.8K ﹤0.01%
450,000

Similar funds

Boothbay Fund Management's Q4 2022 Portfolio in Review

As of Q4 2022, Boothbay Fund Management held 2,841 positions worth $4.32B, up 7.9% from $4.01B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Boothbay Fund Management withdrew a net $173M in Q4 2022, closing 892 positions and reducing 445 holdings. Its most notable exit was Alleghany Corp, an estimated $20.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Boothbay Fund Management opened a new position in Kairos Acquisition Corp. Class A Ordinary Shares worth $12.6M.

  • Boothbay Fund Management's largest Q4 2022 buy was Kairos Acquisition Corp. Class A Ordinary Shares: 1,255,444 shares worth $12.6M.
  • Boothbay Fund Management added most to RMG Acquisition Corp. III Class A Ordinary Shares in Q4 2022, an estimated $19.5M increase.
  • Boothbay Fund Management's biggest Q4 2022 reduction was ADMA Biologics, cutting an estimated $21.8M.
  • Boothbay Fund Management fully exited Alleghany Corp in Q4 2022, selling an estimated $20.1M.
  • Boothbay Fund Management's ten largest holdings make up 10% of its $4.32B portfolio in Q4 2022.
  • Boothbay Fund Management opened 651 new positions and closed 892 in Q4 2022.
  • Boothbay Fund Management's portfolio value rose 7.9% quarter-over-quarter to $4.32B.

Based on Boothbay Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.